Walgreens Boots Alliance (NASDAQ:WBA) Trading Down 1.1%

Walgreens Boots Alliance, Inc. (NASDAQ:WBA)’s stock price fell 1.1% during trading on Thursday . The stock traded as low as $8.53 and last traded at $8.60. 2,678,022 shares were traded during trading, a decline of 84% from the average session volume of 16,363,899 shares. The stock had previously closed at $8.70.

Analyst Ratings Changes

Several analysts have issued reports on WBA shares. JPMorgan Chase & Co. decreased their price target on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating on the stock in a research report on Friday, August 30th. Truist Financial lowered their price target on Walgreens Boots Alliance from $20.00 to $13.00 and set a “hold” rating on the stock in a research note on Friday, June 28th. Morgan Stanley reduced their price objective on Walgreens Boots Alliance from $13.00 to $9.00 and set an “underweight” rating for the company in a research report on Friday, June 28th. Bank of America lowered their price objective on Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating on the stock in a research report on Wednesday, September 4th. Finally, Royal Bank of Canada reduced their target price on Walgreens Boots Alliance from $22.00 to $13.00 and set a “sector perform” rating for the company in a research report on Tuesday, July 2nd. Four research analysts have rated the stock with a sell rating, ten have issued a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $14.73.

Walgreens Boots Alliance Stock Performance

The stock has a 50-day moving average of $9.85 and a 200 day moving average of $14.03. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.31 and a current ratio of 0.65. The firm has a market capitalization of $7.42 billion, a P/E ratio of -1.28, a price-to-earnings-growth ratio of 1.03 and a beta of 0.70.

Walgreens Boots Alliance Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, September 12th. Investors of record on Wednesday, August 21st were given a dividend of $0.25 per share. The ex-dividend date was Wednesday, August 21st. This represents a $1.00 annualized dividend and a yield of 11.63%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is -14.84%.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of WBA. Iron Horse Wealth Management LLC raised its position in shares of Walgreens Boots Alliance by 162.5% during the 2nd quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator’s stock valued at $25,000 after acquiring an additional 1,300 shares during the last quarter. Pineridge Advisors LLC bought a new position in Walgreens Boots Alliance during the fourth quarter worth about $26,000. Blue Trust Inc. grew its position in shares of Walgreens Boots Alliance by 87.0% during the 2nd quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock worth $28,000 after buying an additional 1,081 shares during the period. Continuum Advisory LLC increased its stake in shares of Walgreens Boots Alliance by 71.2% in the 2nd quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock valued at $30,000 after acquiring an additional 1,020 shares during the last quarter. Finally, 1832 Asset Management L.P. raised its position in shares of Walgreens Boots Alliance by 282.1% in the 4th quarter. 1832 Asset Management L.P. now owns 1,219 shares of the pharmacy operator’s stock valued at $32,000 after acquiring an additional 900 shares during the period. Institutional investors and hedge funds own 58.59% of the company’s stock.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.